TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MEDA PHARMS

ImmunologyGastroenterology
Specialty

MEDA PHARMS is a specialty pharmaceutical company focused on Immunology, Gastroenterology.

1960
Since
7
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%
1 drugs
Gastroenterology 50%
1 drugs

Pipeline Strength Pro

Loading...